Oncology Central

ASCO18: Day 4 update

0

Today at our booth

On the final day we had some great talks on PREOPANC-1, PRODIGE 7 and ASPECT. Although we’re sad  to see ASCO 2018 draw to a close, it’s been a fantastic conference and we’re already looking forward to next year!

Remember to sign up for Oncology Central, or follow our Twitter updates @OncologyCentral.

Video highlights

Picture of the Day

Untitled design-3Jade Parker, our Editor speaks with Genomic Health about TAILORx

Tomorrow’s key talk

cancer-cells-immune-immunology

Highlights of the Day Session III Tuesday 5 June, 7:30–9:15 in Hall D1.

Today’s news

Preoperative chemoradiotherapy improves survival time for patients with pancreatic cancer

A randomized Phase III trial has indicated that patients who received a combination of chemotherapy with radiation (chemoradiotherapy) before surgery for pancreatic cancer had a better disease-free survival than those who started their treatment with surgery. Preliminary findings of the trial demonstrate that chemoradiotherapy prior to surgery might be beneficial for patients with pancreatic cancer, with results showing that the 2-year survival rate was higher for those who received this treatment plan.

Read the full story.

High dose of Nexium® with aspirin reduces risk of developing esophageal cancer

Researchers have demonstrated that taking a high dose of esomeprazole (Nexium®) along with a low dose aspirin, for at least 7 years, can reduce the risk of develop a high-grade dyslplasia or esophageal cancer.

Full story here. 

PRODIGE 7 demonstrates that HIPEC may not be necessary for CRC patients

The PRODIGE 7 randomized has demonstrated that for advanced colorectal cancer patients, hyperthermic intra-peritoneal chemotherapy delivered to the abdomen during surgery, may not be necessary.

Discover further details here. 

Best of social media #ASCO18


Share:

Insights

Videos

News Headlines

Leave A Comment

Please wait...

Would you like access to more immuno-oncology content?

Register with Oncology Central to find out the latest news, opinions and journal articles published in the oncology field by leading experts.